Rivastigmine three times daily improves cognition and response in Alzheimer's disease: Commentary

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)116
Number of pages1
JournalEvidence-Based Mental Health
Volume10
Issue number4
DOIs
StatePublished - Nov 2007

Fingerprint

Rivastigmine
Cognition
Alzheimer Disease

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Rivastigmine three times daily improves cognition and response in Alzheimer's disease : Commentary. / Farlow, Martin.

In: Evidence-Based Mental Health, Vol. 10, No. 4, 11.2007, p. 116.

Research output: Contribution to journalArticle

@article{a84b041854564655aafa07a249cbea02,
title = "Rivastigmine three times daily improves cognition and response in Alzheimer's disease: Commentary",
author = "Martin Farlow",
year = "2007",
month = "11",
doi = "10.1136/ebmh.10.4.116",
language = "English",
volume = "10",
pages = "116",
journal = "Evidence-Based Mental Health",
issn = "1362-0347",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Rivastigmine three times daily improves cognition and response in Alzheimer's disease

T2 - Commentary

AU - Farlow, Martin

PY - 2007/11

Y1 - 2007/11

UR - http://www.scopus.com/inward/record.url?scp=79960404913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960404913&partnerID=8YFLogxK

U2 - 10.1136/ebmh.10.4.116

DO - 10.1136/ebmh.10.4.116

M3 - Article

C2 - 17962669

AN - SCOPUS:79960404913

VL - 10

SP - 116

JO - Evidence-Based Mental Health

JF - Evidence-Based Mental Health

SN - 1362-0347

IS - 4

ER -